Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
Status:
Not yet recruiting
Trial end date:
2027-04-01
Target enrollment:
Participant gender:
Summary
First in Human, pilot investigation An Open Label, Monocentric, Pilot Study Evaluating Safety
of ExOlin® in Patients with Poorly Controlled Type 1 Diabetes with High Glucose Fluctuations,
Prone to Severe Hypoglycemia